Treatment With TRAIL/z-VAD-fmk/Birinapant (TzB) Induces Necroptosis and RIPK1/RIPK3 Interaction in Human HT29 Colon Carcinoma Cells. This evidence concerns the gene RIPK3 and digestive system cancer.